Site Search
Search Results
The Real Cost of Cutting Medicaid
acs_can_medicaid_cuts_onepager_for_print.pdf The Real Cost of Cutting Medicaid ...
The Costs of Cancer Survivorship - 2022
Introduction The American Cancer Society defines the term “cancer survivor” as any person with a history of cancer, from the time of diagnosis through the remainder of their life. This report is intended to focus on the costs of cancer for those who have finished active ... – do not end when active treatment ends. Individuals face ongoing financial impact. A 2022 American Cancer Society Cancer Action Network (ACS CAN) survey found that over half of cancer survivors report carrying medical debt from their cancer-related treatments. The Costs of Cancer ...
Insurance Disruptions & the Cost of COVID-19
... coverage disruptions are costly because cancer patients like Franklin who have already met their deductible and maximums near the beginning of the year must pay another deductible and reach their new maximum out-of-pocket amount when they start their new insurance plan. And this problem ... who has prostate cancer, already spent $3,000 on his cancer treatment when he lost his job in layoffs related to COVID-19. Starting a new plan cost him another $8,000 to pay his new deductible and out-of-pocket maximum. By the end of the year, Franklin will have spent almost 3 times more ... disruptions aren’t the only cost of COVID-19 for cancer patients. The pandemic has also resulted in delayed or canceled appointments, which can allow a patient’s cancer to grow, leading to higher treatment costs and worse health outcomes. ACS CAN Fights for Solutions ACS CAN is ...
Spikes in Cost Increase the Burden of Affording Cancer Care
... vulnerable to spikes in their health care costs because many expensive diagnostic tests and treatments are scheduled within a short period of time, so cancer patients spend their deductible and out-of-pocket maximum quickly. These costs can be difficult to manage over the course of a year, and most monthly budgets simply can’t afford these large bills. Over the two years that Carla is in treatment for stage III breast cancer, she experiences a spike in cost of over $8,000 in the first two months of each year. While she may be able to afford to spend this much on her care spread over the whole ...
Just the Facts: Out of Pockets Costs and Breast Cancer Survival
... a ultrasound, MRI, and/or biopsy, may be necessary. These follow-up services are not always fully covered by insurance and often result in out-of-pocket cost sharing for patients. A January 2025 economic analysis by ACS CAN and FTI Consulting examined the impact of cost sharing on follow-up care after a screening mammogram. The study found that many patients face ...
Overall Cancer Costs are Rising
The Problem The U.S. spent approximately $183 billion on cancer-related health care in 2015. This represents a signification portion of the total health care spending in the U.S. And it is expected to keep growing. By 2030 cancer-related health care spending is expected to reach ... These high costs are paid by many people – individual cancer patients and their families, employers, insurance companies and taxpayers. ACS CAN Fights for Solutions ACS CAN wants to ensure that all individuals can afford the right health care services at the right time, no matter where ... policymakers must focus on ensuring affordable access to insurance coverage and health care services, and reducing the overall financial impact of cancer for patients and families. Policymakers can also limit costs of cancer by pursuing policies that promote cancer prevention and early ...
The Critical Role of Preventive Services without Cost Sharing for Cancer Prevention and Survivorship
... screening services alone have averted approximately 4.75 million deaths from breast, cervical, colorectal, lung and prostate cancers. Millions of people risk losing access to preventive services if cost sharing is required. Thanks to current protections in law, a vast majority of Americans have access to preventive services without cost ... negatively impact access to cancer prevention and screening, especially for the millions of people with limited incomes, for whom these payments can represent a significant percentage of their income. The Critical Role of Preventive Services without Cost Sharing for Cancer Prevention and ...
Some Insurance Plans Come with Higher Patient Costs
... helped individuals with pre-existing conditions like cancer access comprehensive health insurance and afford their care. But the law is at risk of being dismantled. The risks of losing ACA protections are clear when you look at current plans that do not have to play by ACA rules. Short-term limited duration plans often ... or other unwelcomed surprises like excluding coverage for a cancer diagnosis as a ‘pre-existing condition.’ For patients with cancer, this can lead to astronomical costs and difficulty affording care. Brian has Stage II lymphoma. When he has a plan that does not include ACA ...
High Deductible Health Plans Cause Extreme Spikes in Cost
The Problem Most patients experience spikes in their health care costs around the time of a cancer diagnosis as they pay their deductible and out-of-pocket maximum. For patients on high deductible plans, this spike can mean bills due for several thousands of dollars within one month. High deductibles often cause individuals to delay or forego care due to cost, which means it may take longer to get a cancer diagnosis and begin life-saving care. And the number of people enrolling in high deductible ...
Some Patients Lack Access to Lower-cost Drug Alternatives
The Problem Many cancer patients take multiple drugs as part of their treatment – often for many months or years. While drugs are not the only costly part of cancer treatment, finding ways to reduce these costs for patients and payers will significantly reduce the overall cost burden of cancer. Biosimilars and generics are lower cost alternative versions to some cancer drugs that may become available after the ... and her insurer nearly $75,000 over two years. If she had access to a biosimilar, those overall costs would have decreased by over 20%. ACS CAN Fights for Solutions ACS CAN supports efforts to ensure biosimilar and generic drugs are available to patients either through prescription from ...
Type
- (-) Remove Resource filter Resource
Priority Issue
Policy Issue
- Access to Health Care (16) Apply Access to Health Care filter
- Prevention and Early Detection (10) Apply Prevention and Early Detection filter
- Research, Funding and Drug Development (3) Apply Research, Funding and Drug Development filter
- Health Equity (2) Apply Health Equity filter
- Patient Quality of Life (2) Apply Patient Quality of Life filter